Histone deacetylase inhibitor suberoyl bis-hydroxamic acid suppresses cell proliferation and induces apoptosis in breast cancer cells

Hydroxamic Acid ◽

Breast Cancer Cells ◽

Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells

Oncology Reports ◽

10.3892/or.2012.2188 ◽

2012 ◽

Vol 29 (3) ◽

pp. 1238-1244 ◽

Cited By ~ 6

Author(s):

HSUEH-TSEN CHENG ◽

WEN-CHUN HUNG

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Hydroxamic Acid ◽

Breast Cancer Cells ◽

Suberoylanilide Hydroxamic Acid ◽

Cytotoxic Effects of Jay Amin Hydroxamic Acid (JAHA), a Ferrocene-Based Class I Histone Deacetylase Inhibitor, on Triple-Negative MDA-MB231 Breast Cancer Cells

Chemical Research in Toxicology ◽

10.1021/tx300376h ◽

2012 ◽

Vol 25 (11) ◽

pp. 2608-2616 ◽

Cited By ~ 43

Author(s):

Mariangela Librizzi ◽

Alessandra Longo ◽

Roberto Chiarelli ◽

Jahanghir Amin ◽

John Spencer ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Hydroxamic Acid ◽

Breast Cancer Cells ◽

Triple Negative ◽

Class I ◽

Cytotoxic Effects ◽

The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells

Oncology Reports ◽

10.3892/or.2011.1488 ◽

2011 ◽

Cited By ~ 4

Author(s):

Bridgette Collins-Burow

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor Trichostatin

Breast Cancer Cells ◽

Trichostatin A ◽

Expression Profiles ◽

Microrna Expression ◽

Deacetylase Inhibitor ◽

Abstract P1-07-01: Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin

10.1158/0008-5472.sabcs13-p1-07-01 ◽

2013 ◽

Author(s):

GJ Sabnis ◽

P Shah ◽

A Kazi ◽

Y Gau ◽

S Chumsri ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Epithelial To Mesenchymal Transition ◽

Mesenchymal Transition ◽

Deacetylase Inhibitor ◽

E Cadherin

Abstract 5847: A histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth with apoptosis in triple-negative breast cancer cells

10.1158/1538-7445.am2018-5847 ◽

2018 ◽

Author(s):

Hisako Ono ◽

Yoshihiro Sowa ◽

Yosuke Iizumi ◽

Mano Horinaka ◽

Tetsuya Taguchi ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Triple Negative Breast Cancer ◽

Breast Cancer Cells ◽

Triple Negative ◽

Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)

Breast Cancer Research and Treatment ◽

10.1007/s10549-012-2332-x ◽

2012 ◽

Vol 137 (1) ◽

pp. 93-107 ◽

Cited By ~ 30

Author(s):

Makoto Kubo ◽

Noriko Kanaya ◽

Karineh Petrossian ◽

Jingjing Ye ◽

Charles Warden ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-14-0778 ◽

2015 ◽

Vol 14 (8) ◽

pp. 1848-1857 ◽

Cited By ~ 41

Author(s):

Amanda Schech ◽

Armina Kazi ◽

Stephen Yu ◽

Preeti Shah ◽

Gauri Sabnis

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Triple Negative Breast Cancer ◽

Breast Cancer Cells ◽

Triple Negative ◽

Tumor Initiating Cells ◽

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL

International Journal of Cancer ◽

10.1002/ijc.21939 ◽

2006 ◽

Vol 119 (4) ◽

pp. 944-954 ◽

Cited By ~ 49

Author(s):

Lisa M. Butler ◽

Vasilios Liapis ◽

Stelios Bouralexis ◽

Katie Welldon ◽

Shelley Hay ◽

...

Keyword(s):

Breast Cancer ◽

Histone Deacetylase ◽

Human Breast Cancer ◽

Hydroxamic Acid ◽

Breast Cancer Cells ◽

Suberoylanilide Hydroxamic Acid ◽

Human Breast Cancer Cells ◽

Human Breast ◽

Histone deacetylase inhibitor- and PMA-induced upregulation of PMCA4b enhances Ca2+ clearance from MCF-7 breast cancer cells

Cell Calcium ◽

10.1016/j.ceca.2013.12.003 ◽

2014 ◽

Vol 55 (2) ◽

pp. 78-92 ◽

Cited By ~ 15

Author(s):

Karolina Varga ◽

Katalin Pászty ◽

Rita Padányi ◽

Luca Hegedűs ◽

Jean-Philippe Brouland ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Deacetylase Inhibitor ◽

Mcf 7

Butyrate, a Histone Deacetylase Inhibitor, Activates the Human IGF Binding Protein-3 Promoter in Breast Cancer Cells: Molecular Mechanism Involves an Sp1/Sp3 Multiprotein Complex

Endocrinology ◽

10.1210/endo.142.9.8380 ◽

2001 ◽

Vol 142 (9) ◽

pp. 3817-3827 ◽

Cited By ~ 50

Author(s):

Gillian E. Walker ◽

Elizabeth M. Wilson ◽

David Powell ◽

Youngman Oh

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Molecular Mechanism ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Multiprotein Complex ◽

Deacetylase Inhibitor ◽

Igf Binding ◽

Igf Binding Protein